MX2016009058A - Compuesto de acido piridilaminoacetico y composicion farmaceutica que contiene aceite de ricino polioxietileno. - Google Patents
Compuesto de acido piridilaminoacetico y composicion farmaceutica que contiene aceite de ricino polioxietileno.Info
- Publication number
- MX2016009058A MX2016009058A MX2016009058A MX2016009058A MX2016009058A MX 2016009058 A MX2016009058 A MX 2016009058A MX 2016009058 A MX2016009058 A MX 2016009058A MX 2016009058 A MX2016009058 A MX 2016009058A MX 2016009058 A MX2016009058 A MX 2016009058A
- Authority
- MX
- Mexico
- Prior art keywords
- castor oil
- pharmaceutical composition
- acid compound
- polyoxyethylene castor
- pyridylaminoacetic acid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Ophthalmology & Optometry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014002809 | 2014-01-10 | ||
| PCT/JP2015/050333 WO2015105134A1 (ja) | 2014-01-10 | 2015-01-08 | ピリジルアミノ酢酸化合物とポリオキシエチレンヒマシ油含有医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2016009058A true MX2016009058A (es) | 2016-09-09 |
Family
ID=53523959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2016009058A MX2016009058A (es) | 2014-01-10 | 2015-01-08 | Compuesto de acido piridilaminoacetico y composicion farmaceutica que contiene aceite de ricino polioxietileno. |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20160317512A1 (https=) |
| EP (2) | EP3093021B1 (https=) |
| JP (5) | JP6012775B2 (https=) |
| KR (6) | KR102111157B1 (https=) |
| CN (2) | CN105828817B (https=) |
| AU (1) | AU2015205268B2 (https=) |
| BR (1) | BR112016015911B1 (https=) |
| CA (1) | CA2934612C (https=) |
| EA (1) | EA031723B1 (https=) |
| ES (2) | ES2953346T3 (https=) |
| GE (2) | GEAP201814216A (https=) |
| IL (1) | IL246654B (https=) |
| MX (1) | MX2016009058A (https=) |
| MY (1) | MY166210A (https=) |
| PH (1) | PH12016501327A1 (https=) |
| SG (1) | SG11201605532YA (https=) |
| TW (1) | TWI612960B (https=) |
| UA (1) | UA121744C2 (https=) |
| WO (1) | WO2015105134A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEP20186917B (en) | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pharmaceutical preparation including pyridylamino acetic acid compound |
| BR112016015909B1 (pt) | 2014-01-10 | 2020-09-29 | Santen Pharmaceutical Co., Ltd. | Composição farmacêutica contendo composto de ácido piridilaminoacético |
| ES2953346T3 (es) * | 2014-01-10 | 2023-11-10 | Santen Pharmaceutical Co Ltd | Composición farmacéutica que contiene un compuesto de ácido piridilaminoacético y aceite de ricino polioxietilenado |
| EP3320904B1 (en) | 2015-07-09 | 2023-07-05 | Santen Pharmaceutical Co., Ltd. | Preventative and/or therapeutic agent containing pyridyl aminoacetic acid compound for treating a disease involving a greatly elevated intraocular pressure |
| EP3639854B1 (en) | 2017-06-16 | 2026-01-07 | The Doshisha | Mtor-inhibitor-containing medicine for treating or preventing fuchs' endothelial corneal dystrophy |
| US20200121652A1 (en) | 2017-06-16 | 2020-04-23 | The Doshisha | Compounds having caspase inhibitory activity, pharmaceutical agent containing said compounds and for treating or preventing corneal endothelial symptoms, disorders, or diseases, and application of said pharmaceutical agent |
| TWI842679B (zh) | 2017-09-29 | 2024-05-21 | 日商參天製藥股份有限公司 | 含有吡啶基胺乙酸化合物之醫藥 |
| WO2019124487A1 (ja) | 2017-12-21 | 2019-06-27 | 参天製薬株式会社 | オミデネパグの組合せ |
| CN111526876A (zh) * | 2017-12-28 | 2020-08-11 | 参天制药株式会社 | 含有吡啶基氨基乙酸化合物的药物制剂 |
| CN114761022B (zh) * | 2019-11-29 | 2024-02-13 | 千寿制药株式会社 | 药物组合物 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4960799A (en) * | 1988-09-13 | 1990-10-02 | Ciba-Geigy Corporation | Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use |
| US5631287A (en) * | 1994-12-22 | 1997-05-20 | Alcon Laboratories, Inc. | Storage-stable prostaglandin compositions |
| JP3297969B2 (ja) * | 1994-12-26 | 2002-07-02 | ライオン株式会社 | 点眼剤 |
| WO2000003736A1 (en) * | 1998-07-14 | 2000-01-27 | Alcon Laboratories, Inc. | Prostaglandin product |
| US6235781B1 (en) * | 1998-07-14 | 2001-05-22 | Alcon Laboratories, Inc. | Prostaglandin product |
| US20020009507A1 (en) * | 2000-01-19 | 2002-01-24 | Alcon Universal Ltd. | Use of polyethoxylated castor oil for the treatment of dry eye |
| JP2002356420A (ja) * | 2001-03-27 | 2002-12-13 | Santen Pharmaceut Co Ltd | 安定な水性液剤 |
| HUE042839T2 (hu) | 2008-03-12 | 2019-07-29 | Ube Industries | Piridilaminoecetsav vegyületek |
| HRP20160104T1 (hr) | 2009-03-30 | 2016-03-25 | Ube Industries | Farmaceutski pripravak za liječenje ili prevenciju glaukoma |
| JP2011057633A (ja) * | 2009-09-11 | 2011-03-24 | Ube Industries Ltd | ピリジルアミノ酢酸化合物を含有する医薬 |
| US20120058983A1 (en) * | 2010-09-02 | 2012-03-08 | Bayer Pharma Aktiengesellschaft | Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
| US20140018350A1 (en) * | 2012-07-13 | 2014-01-16 | Asahi Glass Co., Ltd. | Combination of sulfonamide compound and tafluprost |
| JP2014019650A (ja) * | 2012-07-13 | 2014-02-03 | Santen Pharmaceut Co Ltd | スルホンアミド化合物とタフルプロストの組み合わせ |
| JP6193655B2 (ja) * | 2012-07-13 | 2017-09-06 | 参天製薬株式会社 | スルホンアミド化合物の組み合わせ |
| US9339496B2 (en) * | 2012-07-13 | 2016-05-17 | Santen Pharmaceutical Co., Ltd. | Composition for treating or preventing glaucoma comprising a sulfonamide compound, and a beta-receptor antagonist |
| BR112016015909B1 (pt) * | 2014-01-10 | 2020-09-29 | Santen Pharmaceutical Co., Ltd. | Composição farmacêutica contendo composto de ácido piridilaminoacético |
| ES2953346T3 (es) * | 2014-01-10 | 2023-11-10 | Santen Pharmaceutical Co Ltd | Composición farmacéutica que contiene un compuesto de ácido piridilaminoacético y aceite de ricino polioxietilenado |
| GEP20186917B (en) * | 2014-01-10 | 2018-11-12 | Pharmaceutical Co Ltd Santen | Pharmaceutical preparation including pyridylamino acetic acid compound |
-
2015
- 2015-01-08 ES ES21174649T patent/ES2953346T3/es active Active
- 2015-01-08 KR KR1020187012966A patent/KR102111157B1/ko active Active
- 2015-01-08 EP EP15735607.2A patent/EP3093021B1/en active Active
- 2015-01-08 CN CN201580003056.5A patent/CN105828817B/zh active Active
- 2015-01-08 JP JP2015002271A patent/JP6012775B2/ja active Active
- 2015-01-08 EP EP21174649.0A patent/EP3888654B1/en active Active
- 2015-01-08 CA CA2934612A patent/CA2934612C/en active Active
- 2015-01-08 SG SG11201605532YA patent/SG11201605532YA/en unknown
- 2015-01-08 UA UAA201607761A patent/UA121744C2/uk unknown
- 2015-01-08 KR KR1020247019428A patent/KR20240096869A/ko not_active Ceased
- 2015-01-08 KR KR1020167016400A patent/KR101858373B1/ko active Active
- 2015-01-08 TW TW104100527A patent/TWI612960B/zh active
- 2015-01-08 GE GEAP201814216A patent/GEAP201814216A/en unknown
- 2015-01-08 MX MX2016009058A patent/MX2016009058A/es unknown
- 2015-01-08 GE GEAP201514216A patent/GEP20186916B/en unknown
- 2015-01-08 KR KR1020217007751A patent/KR102458180B1/ko active Active
- 2015-01-08 ES ES15735607T patent/ES2874547T3/es active Active
- 2015-01-08 WO PCT/JP2015/050333 patent/WO2015105134A1/ja not_active Ceased
- 2015-01-08 BR BR112016015911-0A patent/BR112016015911B1/pt active IP Right Grant
- 2015-01-08 KR KR1020207013304A patent/KR102230683B1/ko active Active
- 2015-01-08 EA EA201691139A patent/EA031723B1/ru unknown
- 2015-01-08 KR KR1020227036348A patent/KR102675685B1/ko active Active
- 2015-01-08 AU AU2015205268A patent/AU2015205268B2/en active Active
- 2015-01-08 CN CN201910493497.8A patent/CN110251516B/zh active Active
- 2015-01-08 MY MYPI2016001268A patent/MY166210A/en unknown
-
2016
- 2016-07-04 PH PH12016501327A patent/PH12016501327A1/en unknown
- 2016-07-07 US US15/204,475 patent/US20160317512A1/en not_active Abandoned
- 2016-07-07 IL IL246654A patent/IL246654B/en active IP Right Grant
- 2016-09-16 JP JP2016181739A patent/JP6449205B2/ja active Active
-
2018
- 2018-12-05 JP JP2018227964A patent/JP6793172B2/ja active Active
-
2019
- 2019-12-12 US US16/711,706 patent/US20200113880A1/en not_active Abandoned
-
2020
- 2020-11-09 JP JP2020186245A patent/JP7170020B2/ja active Active
-
2022
- 2022-10-31 JP JP2022174719A patent/JP7546027B2/ja active Active
-
2023
- 2023-08-02 US US18/363,961 patent/US20230372316A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2016009058A (es) | Compuesto de acido piridilaminoacetico y composicion farmaceutica que contiene aceite de ricino polioxietileno. | |
| MX2016009049A (es) | Composicion farmaceutica que contiene compuesto de acido piridilaminoacetico. | |
| PH12018502747A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| TN2016000268A1 (en) | N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of shp2. | |
| EA201692301A1 (ru) | Производные бороновой кислоты и их терапевтическое применение | |
| MX2017005938A (es) | Solución que comprende nicotina en forma desprotonada y en forma protonada. | |
| BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
| BR112014009087A2 (pt) | formulações de etanercept estabilizadas com xilitol | |
| NZ729037A (en) | Carboxylic acid compound, method for preparation thereof, and use thereof | |
| MX2015016971A (es) | Formulacion que comprende un agente hipolipidemico. | |
| CU24330B1 (es) | Derivados del ácido 4-((1,1) bifenil-4-il)-3-(3-fosfonopropanamido) butanoico, activos como inhibidores de nep (endopeptidasa neutral) | |
| AR102767A1 (es) | Inhibidores de ezh2 | |
| EA201592268A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 | |
| EP3480186A4 (en) | NEW ARYLETE HAND DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREFORE AS AN ACTIVE SUBSTANCE | |
| HK1257171A1 (zh) | 间变性淋巴瘤激酶（alk）和丝氨酸富集蛋白激酶 （sppk）的抑制剂及其使用方法 | |
| EA201791396A1 (ru) | ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| MX2017008072A (es) | Formulaciones de un inhibidor de pi3k/mtor para administracion intravenosa. | |
| AR089457A1 (es) | Composicion para el control de plagas | |
| MX390841B (es) | Preparacion liquida parenteral que comprende compuesto de carbamato. | |
| EA201692045A1 (ru) | Производное фенантролинфосфоновой кислоты и способ его получения и применения | |
| EP3459936A4 (en) | NEW ARYLETE HAND DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREFORE AS AN ACTIVE SUBSTANCE | |
| EA201791397A1 (ru) | СВЯЗАННЫЕ С ГЕТЕРОЦИКЛИЛАМИ ПРОИЗВОДНЫЕ ИМИДАЗОПИРИДАЗИНА В КАЧЕСТВЕ ИНГИБИТОРОВ PI3Kβ | |
| UY36160A (es) | “3-arilpirazoles herbicidas sustituidos”. | |
| BR112015029378A2 (pt) | inibidor de crescimento de broto axilar em tabaco e método para inibição de crescimento de broto axilar em tabaco | |
| AR107164A1 (es) | INHIBIDORES DE QUINASA p38 |